The Effect of Red Blood Cells Storage Duration on Biochemical Changes in Pediatric Patients

January 4, 2018 updated by: Abdelrady S Ibrahim, MD

Is Intraoperative Red Blood Cells Transfusion With Different Storage Duration Has Effect on Some Biochemical Parameters in Pediatric Trauma Patients Need Intraoperative Transfusion?

The aim of the study is to detect if the storage duration of red blood cells has impact on some biochemical parameters after intra operative transfusion in pediatric trauma patient

Study Overview

Detailed Description

  • A pretransfusion draw of a few drops of patient venous blood, send for analysis by i-STAT Portable Clinical Analyser. Samples are processed immediately and provide laboratory quality results in 2 minutes using the CHEM 8+ i-STAT cartridge for measurement of:

    1. Potassium (K)
    2. Ionized Calcium (iCa)
    3. Glucose (Glu)
    4. Urea Nitrogen (BUN)/Urea
    5. Hemoglobin (Hb) and Hematocrit (Hct).
  • Concurrently, a few drops of blood will be taken from the unit to be transfused will be analysed by i-STAT Portable Clinical Analyser for measurement of previous biochemical parameters.
  • The details of the unit, such as draw date, volume of transfusion, and date of transfusion, will be recorded. The RBC unit will be delivered to the operative room from the blood bank in an insulated box.
  • The transfusion is then given as clinically indicated at a rate of 50 to 150 mL/h based on the clinician's orders, the patient's weight, and the patient's clinical situation.
  • Volumes will be transfused to children according to the following top-up transfusion equation: desired Hemoglobin (Hb) (g/dl) - actual Hemoglobin (Hb) (g/dl) x weight (kg) x 3. (usually 10-20 ml/kg).
  • A second patient blood sample will be drawn one hour after the transfusion and will be analyzed by i-STAT Portable Clinical Analyser.
  • Patient information will be recorded for age, weight, sex, and primary diagnosis.
  • Demographic and clinical variables will be collected, to include type and quantity of all blood products and fluids received and medications administered. All surgical procedures will be documented.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Assiut, Egypt
        • Assiut University Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 10 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

.ASA I-II physical status patients.

  • Genders Eligible for Study : both .
  • Age: 2_10 years
  • All non-crush trauma pediatric patients need intraoperative RBC transfusion.
  • RBCs transfusion Volume within 10-20ml/kg.

Exclusion Criteria:

  • Patients with renal failure (serum creatinine 1.5 mg/dL)
  • Hepatic insufficiency.
  • Furosemide diuresis.
  • Succinylcholine for rapid sequence induction.
  • Electrolytes disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Group A
Red blood cells unit age 14 days or less
30 Patients who will receive units of packed red blood cells stored stored for 14 days or less
Other: Group B
Red blood cells unit age more than 14 days
30 patients who will receive units of packed red blood cells stored for more than 14 days

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum potassium level
Time Frame: One hour after red blood cells transfusion
Mmol/l
One hour after red blood cells transfusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum ionised calcium
Time Frame: One hour after red blood cells transfusion
mg/dl
One hour after red blood cells transfusion
Serum glucose level
Time Frame: One hour after red blood cells transfusion
Mmol/l
One hour after red blood cells transfusion
Blood Urea Nitrogen
Time Frame: One hour after red blood cells transfusion
mg/dL
One hour after red blood cells transfusion
Hemoglobin level
Time Frame: One hour after red blood cells transfusion
g/dl
One hour after red blood cells transfusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Abdelrady S Ibrahim, Assistant professor of anesthesia and Intensive Care

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

August 1, 2017

Study Registration Dates

First Submitted

March 20, 2016

First Submitted That Met QC Criteria

March 30, 2016

First Posted (Estimate)

March 31, 2016

Study Record Updates

Last Update Posted (Actual)

January 8, 2018

Last Update Submitted That Met QC Criteria

January 4, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • IRB0000871236

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Red Blood Cells Transfusion

Clinical Trials on Red blood cells unit age 14 days or less

Subscribe